Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Viruses ; 16(4)2024 04 18.
Article in English | MEDLINE | ID: mdl-38675967

ABSTRACT

Inactivated influenza A virus (IAV) vaccines help reduce clinical disease in suckling piglets, although endemic infections still exist. The objective of this study was to evaluate the detection of IAV in suckling and nursery piglets from IAV-vaccinated sows from farms with endemic IAV infections. Eight nasal swab collections were obtained from 135 two-week-old suckling piglets from four farms every other week from March to September 2013. Oral fluid samples were collected from the same group of nursery piglets. IAV RNA was detected in 1.64% and 31.01% of individual nasal swabs and oral fluids, respectively. H1N2 was detected most often, with sporadic detection of H1N1 and H3N2. Whole-genome sequences of IAV isolated from suckling piglets revealed an H1 hemagglutinin (HA) from the 1B.2.2.2 clade and N2 neuraminidase (NA) from the 2002A clade. The internal gene constellation of the endemic H1N2 was TTTTPT with a pandemic lineage matrix. The HA gene had 97.59% and 97.52% nucleotide and amino acid identities, respectively, to the H1 1B.2.2.2 used in the farm-specific vaccine. A similar H1 1B.2.2.2 was detected in the downstream nursery. These data demonstrate the low frequency of IAV detection in suckling piglets and downstream nurseries from farms with endemic infections in spite of using farm-specific IAV vaccines in sows.


Subject(s)
Farms , Influenza A virus , Influenza Vaccines , Orthomyxoviridae Infections , Phylogeny , Swine Diseases , Animals , Swine , Swine Diseases/virology , Swine Diseases/epidemiology , Swine Diseases/prevention & control , Orthomyxoviridae Infections/veterinary , Orthomyxoviridae Infections/virology , Orthomyxoviridae Infections/epidemiology , Influenza A virus/genetics , Influenza A virus/immunology , Influenza A virus/isolation & purification , Influenza A virus/classification , Influenza Vaccines/immunology , Influenza Vaccines/administration & dosage , Animals, Suckling , Vaccination/veterinary , Endemic Diseases/veterinary , Influenza A Virus, H1N1 Subtype/genetics , Influenza A Virus, H1N1 Subtype/immunology , Influenza A Virus, H1N1 Subtype/isolation & purification , RNA, Viral/genetics , Influenza A Virus, H3N2 Subtype/genetics , Influenza A Virus, H3N2 Subtype/immunology , Influenza A Virus, H3N2 Subtype/isolation & purification , Influenza A Virus, H1N2 Subtype/genetics , Influenza A Virus, H1N2 Subtype/isolation & purification , Influenza A Virus, H1N2 Subtype/immunology , Genome, Viral
2.
Clin Vaccine Immunol ; 20(9): 1466-72, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23885030

ABSTRACT

Haemophilus parasuis causes Glässer's disease, a syndrome of polyserositis, meningitis, and arthritis in swine. Previous studies with H. parasuis have revealed virulence disparity among isolates and inconsistent heterologous protection. In this study, virulence, direct transmission, and heterologous protection of 4 isolates of H. parasuis (SW114, 12939, MN-H, and 29755) were evaluated using a highly susceptible pig model. In an initial experiment, isolates 12939, MN-H, and 29755 caused Glässer's disease, while strain SW114 failed to cause any clinical signs of disease. One pig from each group challenged with MN-H or 29755 failed to develop clinical disease but was able to transmit H. parasuis to noninfected pigs, which subsequently developed Glässer's disease. Pigs colonized with SW114, 29755, or MN-H that were free of clinical disease were protected from a subsequent challenge with isolate 12939. In a following experiment, pigs vaccinated with strain SW114 given as either a bacterin intramuscularly or a live intranasal vaccine were protected from subsequent challenge with isolate 12939; however, some pigs given live SW114 developed arthritis. Overall these studies demonstrated that pigs infected with virulent isolates of H. parasuis can remain healthy and serve as reservoirs for transmission to naive pigs and that heterologous protection among H. parasuis isolates is possible. In addition, further attenuation of strain SW114 is necessary if it is to be used as a live vaccine.


Subject(s)
Cross Protection , Haemophilus Infections/immunology , Haemophilus Infections/prevention & control , Haemophilus parasuis/immunology , Haemophilus parasuis/pathogenicity , Swine Diseases/immunology , Swine Diseases/prevention & control , Animals , Disease Models, Animal , Haemophilus Infections/transmission , Haemophilus Vaccines/administration & dosage , Haemophilus Vaccines/immunology , Haemophilus parasuis/isolation & purification , Swine , Swine Diseases/transmission
3.
Virus Res ; 169(1): 212-21, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23073232

ABSTRACT

Porcine reproductive and respiratory syndrome virus (PRRSV) is a ubiquitous and costly virus that exhibits substantial sequence and virulence disparity among diverse isolates. In this study, we compared the whole genomic sequence and virulence of 4 Type 2 PRRSV isolates. Among the 4 isolates, SDSU73, MN184, and NADC30 were all clearly more virulent than NADC31, and among the 3 more virulent isolates, there were subtle differences based on viral replication, lung lesions, lymphadenopathy, febrile response, decreased weight gains, and cytokine responses in the lung. Lesions consistent with bacterial bronchopneumonia were present to varying degrees in pigs infected with PRRSV, and bacteria typically associated with the porcine respiratory disease complex were isolated from the lung of these pigs. Genomic sequence evaluation indicates that SDSU73 is most similar to the nucleotide sequence of JA142, the parental strain of Ingelvac(®) PRRS ATP, while the nucleotide sequences of NADC30 and NADC31 are more similar to strain MN184. Both the NADC30 and NADC31 isolates of PRRSV, isolated in 2008, maintain the nonstructural protein 2 (nsp2) deletion seen in MN184 that was isolated in 2001, but NADC31 has two additional 15 and 36 nucleotide deletions, and these strains are 8-14% different on a nucleotide basis from the MN184 strain. These results indicate that newer U.S. Type 2 strains still exhibit variability in sequence and pathogenicity and although PRRSV strains appear to be reducing the size of the nsp2 over time, this does not necessarily mean that the strain is more virulent.


Subject(s)
Genome, Viral , Porcine Reproductive and Respiratory Syndrome/pathology , Porcine Reproductive and Respiratory Syndrome/virology , Porcine respiratory and reproductive syndrome virus/genetics , Porcine respiratory and reproductive syndrome virus/pathogenicity , RNA, Viral/genetics , Animals , Bacteria/isolation & purification , Lung/microbiology , Lung/pathology , Molecular Sequence Data , Porcine respiratory and reproductive syndrome virus/isolation & purification , Sequence Analysis, DNA , Swine , United States , Viral Proteins/genetics , Virulence
4.
Vet Immunol Immunopathol ; 140(1-2): 152-8, 2011 Mar 15.
Article in English | MEDLINE | ID: mdl-21176971

ABSTRACT

The objective of this study was to determine cytokine and chemokine mRNA expression profiles in tracheobronchial lymph nodes from pigs singularly infected with porcine circovirus type 2 (PCV2), Mycoplasma hyopneumoniae (MHYO), or coinfected with both. Twenty-eight pigs were randomly assigned to one of four groups: (1) negative controls (NEG), (2) inoculated with MHYO (IMHYO), (3) inoculated with MHYO and PCV2 (CoI), and (4) inoculated with PCV2 (IPCV2). MHYO infection significantly (P<0.05) stimulated innate cytokines, IL1B and IL8. PCV2 infection significantly stimulated expression of IFNG, IL8, NOS2A and chemokines CCL2, CCL5, and CXCL10. IFNB, IL1B and IL12 were slightly increased with PCV2 infection and IFNA and IL4 were significantly downregulated. Compared to NEG pigs, coinfection resulted in a significant increase in expression of IFNG, IL1B, IL8, CCL5, CXCL10, and weak stimulation of IFNB, IL6 and IL10; IL13 and IFNA were significantly downregulated. Overall MHYO potentiated PCV2 infection by increasing IFNG and IL10 mRNA expression levels. The increase of IFNG and chemokines and decrease of IFNA in IPCV2 and CoI pigs were correlated with increased severity of lymphoid lesions and the presence of PCV2 antigen. In summary, this work provided evidence that the increased severity of lesions in PCV2 and MHYO coinfected pigs was associated mainly with the presence of PCV2 antigen and alterations of cytokine mRNA expression profiles.


Subject(s)
Chemokines/biosynthesis , Circoviridae Infections/veterinary , Circovirus/immunology , Cytokines/biosynthesis , Gene Expression/immunology , Lymph Nodes/metabolism , Mycoplasma hyopneumoniae/immunology , Pneumonia of Swine, Mycoplasmal/immunology , RNA, Messenger/biosynthesis , Swine Diseases/immunology , Animals , Antigens, Viral/analysis , Chemokines/immunology , Circoviridae Infections/immunology , Circoviridae Infections/virology , Cytokines/immunology , Lung/immunology , Lung/pathology , Pneumonia of Swine, Mycoplasmal/microbiology , RNA, Messenger/immunology , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Swine , Swine Diseases/microbiology , Swine Diseases/virology
5.
Clin Vaccine Immunol ; 14(12): 1572-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17928430

ABSTRACT

The objectives of this study were to test the efficacy and safety of planned exposure to porcine reproductive and respiratory syndrome virus (PRRSV) in protecting naïve and previously exposed pigs against PRRSV challenge and to gain information on the dose of PRRSV necessary to induce a protective immune response. Fifty 2-week-old pigs were randomly assigned to one of five groups: a group exposed to a low dose of autogenous PRRSV vaccine (the L-VAC group), a group exposed to a high dose of autogenous vaccine (the H-VAC group), a group exposed to a low dose of a heterologous PRRSV strain (strain SDSU73) prior to planned exposure (the SDSU73-L-VAC group), a group exposed to a high dose of a heterologous PRRSV strain (strain SDSU73) prior to planned exposure (the SDSU73-H-VAC group), and a control group. All groups were challenged with PRRSV VR2385 5 weeks after the planned exposure. Necropsy was done 2 weeks after the PRRSV challenge. The H-VAC, SDSU73-L-VAC, and SDSU73-H-VAC groups had significantly (P < 0.05) less severe clinical disease (sneezing, respiratory scores, and weight gain), significantly (P < 0.05) less severe macroscopic and microscopic lung lesions, and significantly (P < 0.05) lower numbers of PRRSV genomic copy numbers in their sera compared to the results for the control group. Planned exposure to live PRRSV can be used as an inexpensive and effective way to decrease the severity of PRRSV-induced disease following subsequent challenge.


Subject(s)
Porcine respiratory and reproductive syndrome virus/immunology , Swine Diseases/immunology , Swine Diseases/prevention & control , Viral Vaccines/immunology , Viral Vaccines/therapeutic use , Administration, Intranasal , Animals , Antibodies, Viral/blood , Control Groups , Enzyme-Linked Immunosorbent Assay/veterinary , Gene Dosage , Neutralization Tests/veterinary , Porcine respiratory and reproductive syndrome virus/genetics , Porcine respiratory and reproductive syndrome virus/isolation & purification , Porcine respiratory and reproductive syndrome virus/pathogenicity , RNA, Viral/blood , RNA, Viral/isolation & purification , Random Allocation , Risk Factors , Serologic Tests/veterinary , Sus scrofa , Swine Diseases/blood , Swine Diseases/pathology , Swine Diseases/virology , Time Factors , Treatment Outcome , Viral Vaccines/administration & dosage , Viral Vaccines/adverse effects , Viremia
6.
J Am Vet Med Assoc ; 230(2): 244-50, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17223759

ABSTRACT

OBJECTIVE: To identify important pathogens and characterize their serologic and pathologic effects in porcine circovirus type 2 (PCV2)-infected pigs in relation to pig age and type of swine production system. DESIGN: Cross-sectional study. ANIMALS: 583 conventionally reared pigs. PROCEDURES: 3- (n = 157), 9- (149), 16- (152), and 24-week-old (125) pigs from 41 different 1-, 2-, and 3-site production systems (5 pigs/age group/farm) were euthanized and necropsied. Pigs with and without PCV2 infection were identified (via PCR assay); infection with and serologic responses to other pathogens and pathologic changes in various tissues (including lungs) were assessed. Logistic regression models were constructed for effects overall and within each age group and type of production system. RESULTS: Compared with PCV2-negative pigs, PCV2-positive pigs were more likely to have swine influenza virus (SIV) type A and Mycoplasma hyopneumoniae infections and sample-to-positive (S:P) ratios for SIV H1N1 from 0.50 to 0.99; also, PCV2-positive pigs had higher serum anti-porcine reproductive and respiratory syndrome virus (PRRSV) antibody titers and more severe lung tissue damage. Infection with SIV (but lower SIV H1N1 S:P ratio) was more likely in 3-week-old PCV2-positive pigs and evidence of systemic disease was greater in 16-week-old PCV2-positive pigs than in their PCV2-negative counterparts. By site type, associations of coinfections and disease effects between PCV2-positive and -negative pigs were greatest in 3-site production systems. CONCLUSIONS AND CLINICAL RELEVANCE: In PCV2-positive pigs, coinfections with SIV, M. hyopneumoniae, and PRRSV are important, having the greatest effect in the early to late nursery phase and in 3-site production systems.


Subject(s)
Circoviridae Infections/veterinary , Circovirus/pathogenicity , Influenza A virus/pathogenicity , Orthomyxoviridae Infections/veterinary , Pneumonia, Mycoplasma/veterinary , Porcine Reproductive and Respiratory Syndrome/epidemiology , Swine Diseases/epidemiology , Age Factors , Animals , Animals, Newborn , Circoviridae Infections/epidemiology , Comorbidity , Confidence Intervals , Cross-Sectional Studies , Logistic Models , Odds Ratio , Orthomyxoviridae Infections/epidemiology , Pneumonia, Mycoplasma/epidemiology , Porcine respiratory and reproductive syndrome virus/pathogenicity , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...